News
AstraZeneca has paused a 200 million pound sterling ($271 million) investment in its Cambridge, England research site, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback